AstraZeneca Unloads Four NDAs to ANI Pharmaceuticals in $46.5M Deal Post author:Sam Post published:December 28, 2017 Post category:BioPharma ANI Phamaceuticals funded the acquisitions through a combination of cash and debt. Source: BioSpace You Might Also Like Optinose Gets $100M Debt Financing From Athyrium Capital Management January 1, 2018 Ethicon Release: Company Announces Acquisition Of MEGADYNE January 19, 2017 American Diabetes Association And Collaborate To Prevent And Delay Type 2 Diabetes September 4, 2017
